Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ESTA
ESTA logo

ESTA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Establishment Labs Holdings Inc (ESTA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
62.010
1 Day change
5.08%
52 Week Range
83.310
Analysis Updated At
2026/04/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Establishment Labs Holdings Inc (ESTA) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has potential for growth, the current technical indicators, financial performance, and trading trends suggest caution. The recent price weakness may present an opportunity, but the lack of strong positive catalysts and mixed analyst sentiment do not make it an immediate buy.

Technical Analysis

The MACD histogram is negative (-0.275) and contracting, indicating bearish momentum. RSI is at 43.447, in the neutral zone, showing no clear trend. Moving averages are converging, suggesting indecision. Key support is at 54.264, and resistance is at 64.146. The stock is trading below the pivot point of 59.205, indicating weakness.

Options Data

Neutral
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • Mizuho views the current weakness as an attractive entry point, citing robust demand and overdone macro concerns. Analysts have raised price targets recently, with some projecting growth potential. Gross margin improved to 70.46%, up 2.86% YoY.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily, with a 348.78% increase in selling activity. Insider trading is neutral, with no significant activity. The stock has a high chance of declining in the next week (-0.87%) and month (-8.73%). Financial performance shows a significant drop in net income (-92.43% YoY) and EPS (-92.44% YoY).

Financial Performance

In Q4 2025, revenue increased by 45.16% YoY to $64.62M, indicating strong top-line growth. However, net income dropped significantly to -$2.615M (-92.43% YoY), and EPS fell to -0.09 (-92.44% YoY). Gross margin improved to 70.46%, up 2.86% YoY, showing operational efficiency.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Mizuho maintains an Outperform rating with a $100 price target, citing the current weakness as an attractive entry point. Canaccord, TD Cowen, and Stephens have raised price targets, emphasizing growth potential. However, Citi lowered its price target to $74 and remains Neutral, reflecting caution.

Wall Street analysts forecast ESTA stock price to rise
8 Analyst Rating
Wall Street analysts forecast ESTA stock price to rise
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 59.010
sliders
Low
75
Averages
82.88
High
90
Current: 59.010
sliders
Low
75
Averages
82.88
High
90
Citi
Joanne Wuensch
Neutral
downgrade
$74 -> $65
AI Analysis
2026-04-07
New
Reason
Citi
Joanne Wuensch
Price Target
$74 -> $65
AI Analysis
2026-04-07
New
downgrade
Neutral
Reason
Citi analyst Joanne Wuensch lowered the firm's price target on Establishment Labs to $65 from $74 and keeps a Neutral rating on the shares. The firm adjusted targets in the medical technology group as part of a Q1 preview. The "walls of worry are high" into the earnings reports with the sector undergoing significant multiple compression, the analyst tells investors in a research note. Citi removed iRhythm and Medtronic as top picks. The firm's top picks are now Edwards Lifesciences and Intuitive Surgical.
Mizuho
Mizuho
Outperform
maintain
$100
2026-03-24
Reason
Mizuho
Mizuho
Price Target
$100
2026-03-24
maintain
Outperform
Reason
Mizuho says Establishment Labs shares are down 28% since February 28, the first day of the U.S.-Iran conflict, which is "unwarranted and overdone." Establishment has pulled back on concerns that rising oil prices will pressure the company's margins and consumer demand, the analyst tells investors in a research note. Mizuho adds that the stock has been weak more recently on "unsubstantiated evidence" of a short report and insider selling from former CEO Jaun Jose Chacon. The firm believes the macro concerns are "well overdone" considering Establishment purchases silicone under forward contracts while demand at the consumer level, particularly for Preserve, "remains robust." Further, no short report was published, and insider selling is part of a planned previously disclosed 10b5-1 plan, contends Mizuho. As such, it views the stock's current weakness as an "attractive entry point into a best-in-class growth story." Mizuho has an Outperform rating on Establishment Labs with a $100 price target. The stock is down 6% to $56.29 in afternoon trading.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ESTA
Unlock Now

People Also Watch